GT BIOPHARMA, INC. Stock-Based Compensation
GT BIOPHARMA, INC. (GTBP) reported Stock-Based Compensation of $46.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-05-15
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $46.00K, a 1433.33% increase year-over-year.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $46.00K, a 475.00% increase year-over-year.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $379.00K.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-06-30 was $4.00K, a 96.67% decline year-over-year.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $432.00K, a 87.83% increase from fiscal 2024.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $230.00K.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $7.70M, a 77.29% decline from fiscal 2021.
- GT BIOPHARMA, INC. share-based payment arrangement, noncash expense for fiscal 2021 was $33.90M, a 12502.23% increase from fiscal 2020.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-03-31 | $46.00K 10-Q · filed 2026-05-15 | $92.00K derived: sum of 2 quarters · filed 2026-05-15 | $471.00K derived: sum of 3 quarters · filed 2026-05-15 | $475.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-12-31 | $46.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | $425.00K derived: sum of 2 quarters · filed 2026-03-06 | $429.00K derived: sum of 3 quarters · filed 2026-03-06 | $432.00K 10-K · filed 2026-03-02 | |||
| 2025-09-30 | $379.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2026-03-06 | $383.00K derived: sum of 2 quarters · filed 2026-03-06 | $386.00K 10-Q/A · filed 2026-03-06 | $394.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-06-30 | $4.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-03-06 | $7.00K 10-Q/A · filed 2026-03-06 | $15.00K derived: sum of 3 quarters · filed 2026-05-15 | $15.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-15 | $11.00K derived: sum of 2 quarters · filed 2026-05-15 | $11.00K derived: sum of 3 quarters · filed 2026-05-15 | $131.00K derived: sum of 4 quarters · filed 2026-05-15 | |||
| 2024-12-31 | $8.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-03-02 | $8.00K derived: sum of 2 quarters · filed 2026-03-06 | $128.00K derived: sum of 3 quarters · filed 2026-03-06 | $230.00K 10-K · filed 2026-03-02 | |||
| 2024-09-30 | $0.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2026-03-06 | $120.00K derived: sum of 2 quarters · filed 2026-03-06 | $222.00K 10-Q/A · filed 2026-03-06 | ||||
| 2024-06-30 | $120.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2026-03-06 | $222.00K 10-Q/A · filed 2026-03-06 | |||||
| 2024-03-31 | $102.00K 10-Q · filed 2025-05-15 | ||||||
| 2022-12-31 | $7.70M 10-K · filed 2023-03-30 | ||||||
| 2022-06-30 | $127.00K 10-Q · filed 2022-08-15 | ||||||
| 2021-12-31 | $23.44M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $25.40M derived: sum of 2 quarters · filed 2022-03-28 | $25.73M derived: sum of 3 quarters · filed 2022-08-15 | $33.90M 10-K · filed 2022-03-28 | |||
| 2021-09-30 | $1.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $2.29M derived: sum of 2 quarters · filed 2022-08-15 | $10.46M 10-Q · filed 2021-11-10 | $11.05M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-06-30 | $327.00K 10-Q · filed 2022-08-15 | $8.50M 10-Q · filed 2022-08-15 | $9.10M derived: sum of 3 quarters · filed 2022-08-15 | $8.95M derived: sum of 4 quarters · filed 2022-08-15 | |||
| 2021-03-31 | $8.50M 10-Q · filed 2022-05-16 | $9.81M 10-Q · filed 2021-05-17 | $8.77M derived: sum of 2 quarters · filed 2022-05-16 | $8.62M derived: sum of 3 quarters · filed 2022-05-16 | $8.77M derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | $269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | $122.00K derived: sum of 2 quarters · filed 2021-11-10 | $269.00K derived: sum of 3 quarters · filed 2021-11-10 | $269.00K 10-K · filed 2021-04-16 | |||
| 2020-09-30 | -$147.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | $327.00K 10-Q · filed 2020-11-13 | -$894.00K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $147.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-18 | $147.00K 10-Q/A · filed 2020-08-18 | -$747.00K derived: sum of 3 quarters · filed 2021-05-17 | $1.75M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | -$894.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.60M derived: sum of 3 quarters · filed 2021-05-17 | $2.74M derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | -$894.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-16 | $1.60M derived: sum of 2 quarters · filed 2021-04-16 | $2.74M derived: sum of 3 quarters · filed 2021-04-16 | $5.31M 10-K · filed 2021-04-16 | |||
| 2019-09-30 | $2.50M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-13 | $3.64M derived: sum of 2 quarters · filed 2020-11-13 | $6.20M 10-Q · filed 2020-11-13 | $7.71M derived: sum of 4 quarters · filed 2020-11-13 | |||
| 2019-06-30 | $1.14M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-08-18 | $3.71M 10-Q/A · filed 2020-08-18 | $5.21M derived: sum of 3 quarters · filed 2020-08-18 | $6.91M derived: sum of 4 quarters · filed 2020-08-18 | |||
| 2019-03-31 | $2.56M 10-Q · filed 2020-05-15 | $4.07M derived: sum of 2 quarters · filed 2020-05-15 | $5.77M derived: sum of 3 quarters · filed 2020-05-15 | $9.20M derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $3.21M derived: sum of 2 quarters · filed 2020-03-27 | $6.64M derived: sum of 3 quarters · filed 2020-03-27 | $9.70M 10-K · filed 2020-03-27 | |||
| 2018-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $5.13M derived: sum of 2 quarters · filed 2019-11-14 | $8.19M 10-Q · filed 2019-11-14 | $12.41M derived: sum of 4 quarters · filed 2019-11-14 | |||
| 2018-06-30 | $3.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $6.49M 10-Q · filed 2019-08-14 | $10.71M derived: sum of 3 quarters · filed 2019-08-14 | $135.09M derived: sum of 4 quarters · filed 2019-08-14 | |||
| 2018-03-31 | $3.06M 10-Q · filed 2019-05-15 | $7.28M derived: sum of 2 quarters · filed 2019-05-15 | $131.66M derived: sum of 3 quarters · filed 2019-05-15 | $132.31M derived: sum of 4 quarters · filed 2019-05-15 | |||
| 2017-12-31 | $4.22M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $128.60M derived: sum of 2 quarters · filed 2019-03-29 | $129.25M derived: sum of 3 quarters · filed 2019-03-29 | $130.12M 10-K · filed 2019-03-29 | |||
| 2017-09-30 | $124.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $125.03M derived: sum of 2 quarters · filed 2018-11-14 | $125.91M 10-Q · filed 2018-11-14 | $126.68M derived: sum of 4 quarters · filed 2018-11-14 | |||
| 2017-06-30 | $651.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $1.52M 10-Q · filed 2018-08-14 | $2.30M derived: sum of 3 quarters · filed 2018-08-14 | $4.06M derived: sum of 4 quarters · filed 2018-08-14 | |||
| 2017-03-31 | $873.00K 10-Q · filed 2018-05-15 | $1.65M derived: sum of 2 quarters · filed 2018-05-15 | $3.41M derived: sum of 3 quarters · filed 2018-05-15 | $4.34M derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | $779.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-01 | $2.54M derived: sum of 2 quarters · filed 2018-03-01 | $3.47M derived: sum of 3 quarters · filed 2018-03-01 | $6.59M 10-K · filed 2018-03-01 | |||
| 2016-09-30 | $1.76M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | $2.69M derived: sum of 2 quarters · filed 2018-02-28 | $5.81M 10-Q/A · filed 2018-02-28 | $7.75M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-06-30 | $927.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | $4.05M 10-Q/A · filed 2018-02-28 | $5.99M derived: sum of 3 quarters · filed 2018-02-28 | $7.58M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2016-03-31 | $3.12M 10-Q/A · filed 2018-02-28 | $5.07M derived: sum of 2 quarters · filed 2018-02-28 | $6.65M derived: sum of 3 quarters · filed 2018-02-28 | $6.72M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-12-31 | $1.94M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2018-02-28 | $3.53M derived: sum of 2 quarters · filed 2018-02-28 | $3.60M derived: sum of 3 quarters · filed 2018-02-28 | $3.76M 10-K/A · filed 2018-02-28 | |||
| 2015-09-30 | $1.59M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2018-02-28 | $1.66M derived: sum of 2 quarters · filed 2018-02-28 | $1.82M 10-Q/A · filed 2018-02-28 | $4.45M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-06-30 | $68.00K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2018-02-28 | $231.00K 10-Q/A · filed 2018-02-28 | $2.86M derived: sum of 3 quarters · filed 2018-02-28 | $2.86M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2015-03-31 | $163.00K 10-Q/A · filed 2018-02-28 | $2.79M derived: sum of 2 quarters · filed 2018-02-28 | $2.79M derived: sum of 3 quarters · filed 2018-02-28 | $2.79M derived: sum of 4 quarters · filed 2018-02-28 | |||
| 2014-12-31 | $2.63M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-02-28 | $2.63M derived: sum of 2 quarters · filed 2018-02-28 | $2.63M derived: sum of 3 quarters · filed 2018-02-28 | $2.63M 10-K/A · filed 2018-02-28 | |||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $0.00 derived: sum of 2 quarters · filed 2015-11-13 | $0.00 10-Q · filed 2015-11-13 | $1.00K derived: sum of 4 quarters · filed 2015-11-13 | |||
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $0.00 10-Q · filed 2015-08-14 | $1.00K derived: sum of 3 quarters · filed 2015-08-14 | $1.00K derived: sum of 4 quarters · filed 2015-08-14 | |||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-14 | $1.00K derived: sum of 2 quarters · filed 2015-05-14 | $1.00K derived: sum of 3 quarters · filed 2015-05-14 | $1.00K derived: sum of 4 quarters · filed 2015-05-14 | |||
| 2013-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $1.00K derived: sum of 2 quarters · filed 2015-03-31 | $1.00K derived: sum of 3 quarters · filed 2015-03-31 | $176.00K 10-K · filed 2015-03-31 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-01-08 | $0.00 derived: sum of 2 quarters · filed 2015-01-08 | $175.00K 10-Q · filed 2015-01-08 | $405.00K derived: sum of 4 quarters · filed 2015-01-08 | |||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-08 | $175.00K 10-Q · filed 2015-01-08 | $405.00K derived: sum of 3 quarters · filed 2015-01-08 | $683.00K derived: sum of 4 quarters · filed 2015-01-08 | |||
| 2013-03-31 | $175.00K 10-Q · filed 2015-01-08 | $405.00K derived: sum of 2 quarters · filed 2015-01-08 | $683.00K derived: sum of 3 quarters · filed 2015-01-08 | $961.00K derived: sum of 4 quarters · filed 2015-01-08 | |||
| 2012-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-01-08 | $508.00K derived: sum of 2 quarters · filed 2015-01-08 | $786.00K derived: sum of 3 quarters · filed 2015-01-08 | $929.00K 10-K · filed 2015-01-08 | |||
| 2012-09-30 | $278.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-12-17 | $556.00K derived: sum of 2 quarters · filed 2014-12-17 | $699.00K 10-Q · filed 2014-12-17 | $880.00K derived: sum of 4 quarters · filed 2014-12-17 | |||
| 2012-06-30 | $278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-12 | $421.00K 10-Q · filed 2014-12-12 | $602.00K derived: sum of 3 quarters · filed 2014-12-12 | $668.00K derived: sum of 4 quarters · filed 2014-12-12 | |||
| 2012-03-31 | $143.00K 10-Q · filed 2014-12-10 | $324.00K derived: sum of 2 quarters · filed 2014-12-10 | $390.00K derived: sum of 3 quarters · filed 2014-12-10 | $406.00K derived: sum of 4 quarters · filed 2014-12-10 | |||
| 2011-12-31 | $181.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-11-18 | $247.00K derived: sum of 2 quarters · filed 2014-11-18 | $263.00K derived: sum of 3 quarters · filed 2014-11-18 | $307.00K 10-K · filed 2014-11-18 | $30.70K 10-K · filed 2012-04-16 | ||
| 2011-09-30 | $66.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-21 | $82.00K derived: sum of 2 quarters · filed 2012-11-21 | $126.00K 10-Q · filed 2012-11-21 | -$294.00K derived: sum of 4 quarters · filed 2012-11-21 | |||
| 2011-06-30 | $16.00K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-13 | $60.00K 10-Q/A · filed 2012-09-13 | -$360.00K derived: sum of 3 quarters · filed 2012-09-13 | -$346.00K derived: sum of 4 quarters · filed 2012-09-13 | |||
| 2011-03-31 | $44.00K 10-Q · filed 2012-05-21 | -$376.00K derived: sum of 2 quarters · filed 2012-05-21 | -$362.00K derived: sum of 3 quarters · filed 2012-05-21 | ||||
| 2010-12-31 | -$420.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | -$406.00K derived: sum of 2 quarters · filed 2012-04-16 | $149.00K 10-K · filed 2012-04-16 | ||||
| 2010-09-30 | $14.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $569.00K 10-Q · filed 2011-11-21 | |||||
| 2010-06-30 | $555.00K 10-Q/A · filed 2011-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |